C07D 231 - Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings

Patents for C07D 231 - Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings (25,550)
11/2004
11/18/2004	US20040229910 Therapeutic compounds
11/18/2004	US20040229874 5HT7 Antagonists and inverse agonists
11/18/2004	US20040229848 For therapy of non-insulin dependent diabetes
11/18/2004	CA2526904A1 Blockers of the quorum sensing system of gram-negative bacteria
11/18/2004	CA2525325A1 Pyrazole-amides and sulfonamides as sodium channel modulators
11/18/2004	CA2524397A1 Cannabinoid receptor ligands and uses thereof
11/18/2004	CA2524321A1 Aryl-substituted pyrazole-amide compounds useful as kinase inhibitors
11/18/2004	CA2524318A1 4-bromo-5-(2-chloro-benzoylamino)-1h-pyrazole-3-carboxylic acid (phenyl) amide derivates and related compounds as bradykinin b1 receptor antagonists for the treatment of inflamatory diseases
11/18/2004	CA2524274A1 4-bromo-5-(2-chloro-benzoylamino)-1h-pyrazole-3-carboxylic acid (1-(aminocarbonyl)eth-1-yl) amide derivatives and related compounds as bradykinin b1 receptor antagonists for the treatment of inflammatory diseases
11/18/2004	CA2524269A1 4- bromo - 5 - (2- chloro - benzoylamino) - 1h - pyrazole - 3 - carboxylic acid amide derivatives and related compounds as bradykinin b1 receptor antagonists for the treatment of inflammatory diseases
11/18/2004	CA2524009A1 Use of effectors of glutaminyl and glutamate cyclases
11/17/2004	EP1477485A1 Aminophenol derivatives
11/17/2004	EP1476432A1 Therapeutic substituted indazole derivatives
11/17/2004	EP1476431A1 Tricyclic pyrazole derivatives for the treatment of inflammation
11/17/2004	EP1476423A2 Arylsulfonamidobenzylic compounds
11/17/2004	EP1476421A2 Novel amino acid derivatives, method for production thereof and pharmaceutical compositions comprising said derivative
11/17/2004	EP1476419A2 N-biphenylmethyl aminocycloalkanecarboxamide derivatives
11/17/2004	EP1210333B1 p-Tolyl-heterocycles as herbicides
11/17/2004	EP1098885B1 Imidazole compounds and their use as adenosine deaminase inhibitors
11/17/2004	CN1176078C Sulfenylation process of pyrazole compounds with trifluoromethane sulfenyl group
11/11/2004	WO2004096818A2 Method and compositions for identifying anti-hiv therapeutic compounds
11/11/2004	WO2004096801A1 Cannabinoid receptor ligands and uses thereof
11/11/2004	WO2004096795A2 C-fms kinase inhibitors
11/11/2004	WO2004096757A1 Aminopropanol derivatives as sphingosine-1-phosphate receptor modulators
11/11/2004	WO2004096212A1 Pyrazole compounds as hsp90 inhibitors for the treatment of cancer
11/11/2004	WO2004080376A3 Hydroxyethylamine compounds having asp2 inhibitory activity for the treatment of alzheimer’s disease
11/11/2004	WO2003079973A3 Mitotic kinesin inhibitors
11/11/2004	US20040225013 Acylated 6,7,8,9-tetrahydro-5H-benzocycloheptenyl amines and their use as pharmaceutical agents
11/11/2004	US20040224945 Novel substituted pyrazole derivatives
11/11/2004	US20040224875 Inhibitors of glutaminyl cyclase
11/11/2004	CA2536964A1 C-fms kinase inhibitors
11/11/2004	CA2523677A1 Aminopropanol derivatives as sphingosine-1-phosphate receptor modulators
11/11/2004	CA2520842A1 Cannabinoid receptor ligands and uses thereof
11/10/2004	EP1475369A1 Process for producing 3-unsubstituted 5-amino-4-nitrosopyrazole compound, and 2-hydroxyimino-3-oxopropionitrile, 3-hydrazono-2-hydroxyiminopropionitrile compound, and processes for producing these
11/10/2004	EP1475092A1 Blockers of the quorum sensing system of Gram-negative bacteria
11/10/2004	EP1474405A2 Process for the preparation of 4-hetero-substituted phenylalanine derivatives
11/10/2004	EP1140181B1 Combination therapy of radiation and a cox-2 inhibitor for the treatment of neoplasia
11/10/2004	CN1545504A Indazole-aminoacetonitrile derivatives having special pesticidal activity
11/10/2004	CN1544420A Inhibition of raf kinase using substituted heterocyclic ureas
11/10/2004	CN1174981C Imidazole [1,2-A] pyridine and pyrazole [2,3-a] pyridine derivatives
11/10/2004	CN1174970C Method for preparing 3-haloalkyl-1H-pyrazoles
11/09/2004	US6815460 Process for preparing prodrugs of benzenesulfonamide-containing cox-2 inhibitors
11/04/2004	WO2004094423A1 Processes for producing pyrazoloacridone derivative and intermediate therefor
11/04/2004	WO2004094411A1 Pyrazole derivatives as phosphodiesterase 4 inhibitors
11/04/2004	WO2004094388A2 Indazole derivatives as jnk inhibitors
11/04/2004	WO2004094384A2 (hetero) arylamide 2-hydroxy-3-diaminoalkanes for use in the treatment of alzheimer’s disease
11/04/2004	WO2004094370A2 Antibacterial pyrazole carboxylic acid hydrazides
11/04/2004	WO2004093872A1 3-oxo-1, 3-dihydro-indazole-2-carboxylic acid amide derivatives as phospholipase inhibitors
11/04/2004	WO2004093805A2 Selective spirocyclic glucocorticoid receptor modulators
11/04/2004	WO2004067703A3 5ht7 antagonists and inverse agonists
11/04/2004	WO2004061084A3 Modulation of protein functionalities
11/04/2004	WO2003077847A3 Substituted amides
11/04/2004	US20040220232 Organometallic reagent reacted with an activated carboxylic acid to produce a ketone which is reacted with carbon disulfide and dihalomethane, further reacting the dithietane product with a secondary amine, and condensing the thioamide with hydrazine; useful as p38 kinase and COX-2 inhibitors
11/04/2004	US20040220188 Alkylidene pyrazolidinedione derivatives
11/04/2004	US20040220173 central nervous system disorders; psychological disorders; Parkinson's disease; Huntington's disease ; sleep disorders
11/04/2004	US20040220172 Uracil substituted phenyl sulfamoyl carboxamides
11/04/2004	US20040220170 analgesics; reduction of pain
11/04/2004	CA2523232A1 (hetero) arylamide 2-hydroxy-3-diaminoalkanes for use in the treatment of alzheimer's disease
11/04/2004	CA2522946A1 Selective spirocyclic glucocorticoid receptor modulators
11/04/2004	CA2522687A1 Pyrazole derivatives as phosphodiesterase 4 inhibitors
11/04/2004	CA2522682A1 Indazole derivatives as jnk inhibitors
11/04/2004	CA2497410A1 Antibacterial pyrazole carboxylic acid hydrazides
11/03/2004	EP1473292A1 Aromatic heterocyclic compounds as anti-inflammatory agents
11/03/2004	EP1473288A1 Nitric ester derivatives of COX-2 inhibitors and their use for treating inflammation and cardiovascular diseases
11/03/2004	EP1472260A2 Thieno(3,2-b)pyridones as antiviral compounds
11/03/2004	EP1472229A1 5-ring heterocycles used as antiviral agents
11/03/2004	EP1472214A2 Compounds for inhibiting insulin secretion and methods related thereto
11/03/2004	EP1144382B1 Process for preparing 1,5-diaryl-3-substituted pyrazoles
11/03/2004	CN1543460A Ortho-heterocyclic substituted aryl amides for controlling invertebrate pests
11/03/2004	CN1543453A 6-(aryl-amido or aryl-amidomethyl)-naphthalen-2-yloxy-acidic derivatives as inhibitors of plasminogen activator inhibitor type-1 (PAI-1)
11/03/2004	CN1543452A 1,4-disubstituted benzenes as insecticides
11/03/2004	CN1543344A Aryl(or hetero aryl) aza cyclopentadienyl carbinol ramifications for treating urinary incontinence
11/02/2004	US6812347 Alkylating secondary amide group of such as 1-(2,6-dichloro-4-trifluoromethylphenyl)-3-cyano-4-trifluoromethylsulfinyl-5-(ethoxyacetamido)pyrazole; byproduct inhibition; eliminates final purification step
11/02/2004	CA2315614C Pyrazoles
10/2004
10/28/2004	WO2004092155A1 Fluoro-and trifluoroalkyl-containing heterocyclic sulfonamide inhibitors of beta amyloid production and derivatives thereof
10/28/2004	WO2004092146A2 N- (((((1,3-thiazol-2-yl) amino) carbonyl) phenyl) sulfonyl) phenylalanine derivatives and related compounds for the treatment of diabetes
10/28/2004	WO2004092140A1 Biaryl substituted pyrazoles as sodium channel blockers
10/28/2004	WO2004092139A2 Inhibitors of cyclin-dependent kinases, compositions and uses related thereto
10/28/2004	WO2004092115A2 Hydroxamates as therapeutic agents
10/28/2004	WO2004091669A1 Bifunctional tridentate pyrazolyl containing ligands for re and tc tricarbonyl complexes
10/28/2004	WO2004078732B1 N-aryl heteroaromatic products, compositions containing same and use thereof
10/28/2004	WO2004058721A3 Pyrazole derivatives modulators of hepatocyte growth factor (scatter factor) activity
10/28/2004	US20040215000 Ttivalent lanthanide metal complex with pyrazole compounds for electroluminescent flat panel displays
10/28/2004	US20040214890 1,3-diamino-2-hydroxypropane derivatives are useful as inhibitors of the beta-secretase enzyme that are useful in the treatment of Alzheimer's disease and other diseases characterized by deposition of A beta peptide in a mammal
10/28/2004	US20040214837 such as 3-(4-chlorophenyl)-2-(2,4-dichlorophenyl)-7-(4-methylpiperazin-1-yl)-2H-pyrazolo[4,3-d]pyrimidine; for treatment of eating disorders and psychological disorders
10/28/2004	US20040214827 for the treatment and/or prevention of medical dysfunctions and diseases such as stroke, Parkinson's disease, and Alzheimer's disease caused by reactive oxygen species and/or excess Zn ions; neuroprotectants
10/28/2004	CA2522080A1 N- (((((1,3-thiazol-2-yl) amino) carbonyl) phenyl) sulfonyl) phenylalanine derivatives and related compounds for the treatment of diabetes
10/28/2004	CA2520804A1 Biaryl substituted pyrazoles as sodium channel blockers
10/28/2004	CA2517155A1 Fluoro-and trifluoroalkyl-containing heterocyclic sulfonamide inhibitors of beta amyloid production and derivatives thereof
10/27/2004	EP1272456B1 Hydrazide and alkoxyamide angiogenesis inhibitors
10/27/2004	CN1541206A Substituted dihydro 3-hylo-1H-pyrazoloe-5-carboxylates their prepn. and use
10/27/2004	CN1541205A Diamide invertebrate pest control agents contg. non-aromatic heterocyclic ring
10/27/2004	CN1541063A Method for controlling particular insects by applying anthranilamide compounds
10/26/2004	US6809111 Antiinflammatory agents; analgesics
10/26/2004	US6809089 Sulfonylaminocarboxylic acid N-arylamides as guanylate cyclase activators
10/21/2004	WO2004089932A1 Substituted pyrazole compounds
10/21/2004	WO2004089931A1 Substituted pyrazoles
10/21/2004	WO2004089927A1 Novel methods for the treatment of inflammatory diseases
10/21/2004	WO2004089911A1 Pyrazole derivatives as gamma-secretase inhibitors useful in the treatment of alzheimer’s disease
10/21/2004	WO2004089910A1 1,3,4-substituted pyrazoles for use as 5-ht receptor antagonists in the treatment of psychoses and neurological disorders

1 ... 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 ... 256